Retinal toxicity screening methods

Details Retinal toxicity screening methods Retinal toxicity screening methods

G - Physics

01

N

G01N 33/50 (2006.01)

Patent

CA 2550312

The present invention relates to methods for characterizing a test agent using a fluorescently detectable .alpha.v.szlig.3 and .alpha.v.beta.5 integrin specific agent and a retinal pigment epithelial cell. The invention further relates to kits having a fluorescently detectable .alpha.v.beta.3 and .alpha.v.beta.5 integrin specific agent and a retinal pigment epithelial cell.

L'invention concerne des méthodes permettant de caractériser un agent d'essai à l'aide d'un agent spécifique des intégrines v?.szlig.¿3? et ¿v5 détectable par fluorescence et une cellule épithéliale pigmentaire rétinienne. L'invention concerne également des kits comprenant ledit agent spécifique des intégrines v.szlig.3 et v5 détectable par fluorescence et une cellule épithéliale pigmentaire rétinienne.?¿

Affiliated with

Also associated with

Rating

Retinal toxicity screening methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retinal toxicity screening methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinal toxicity screening methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1824986